PRESIDENTS David KHAYAT, MD, PhD - Paris, France Gabriel N. HORTOBAGYI, MD, PhD - Houston, USA GENERAL SECRETARIES Robert S. Benjamin, MD, PhD - Houston, USA Daniel G. Haller, MD - Philadelphia, USA Peter Harper, MD - London, UK Moïse Namer, MD, PhD - Nice, France Paris, France Palais des Congrès 1 st - 5 th February 2010 1 st announcement A World Leading Educational meeting
7
Embed
A World Leading Educational meeting - medicongres.net · TAILLADE Laurent Paris – France THATCHER Nicholas Manchester – UK TOURNIGAND Christophe Paris – France TRILLET-LENOIR
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
PRESIDENTS
David KHAYAT, MD, PhD - Paris, France
Gabriel N. HORTOBAGYI, MD, PhD - Houston, USA
GENERAL SECRETARIES
Robert S. Benjamin, MD, PhD - Houston, USA
Daniel G. Haller, MD - Philadelphia, USA
Peter Harper, MD - London, UK
Moïse Namer, MD, PhD - Nice, France
Paris, FrancePalais des Congrès1st - 5th February 2010
1st announcement
A World Leading Educational meeting
America
Asie & pacific
Europe
ARMITAGE James O. Omaha – USA
BENJAMIN Robert S. Houston – USA
BIZZARI Jean-Pierre New York – USA
DE LA GARZA Jaime Mexico DF – Mexico
CAZAP Eduardo Buenos Aires – Argentina
HALLER Daniel G. Philadelphia – USA
HONG Waun Ki Houston – USA
HORTOBAGYI Gabriel N. Houston – USA
HUDIS Clifford New York – USA
KRIS Mark G. New York – USA
MENDELSOHN John Houston – USA
PEREZ Edith Jacksonville – USA
SALTZ Leonard New York – USA
SWAIN Sandra Washington – USA
SHEPHERD Frances Toronto – Canada
TEMPERO Margaret A. San Francisco – USA
WOLMARK Norman Pittsburgh – USA
AZIZ Zeba Lahore – Pakistan
FUJIWARA Yasuhiro Tokyo – Japan
HAO Chun-Yi Beijing – China
JAMIESON Glyn Adelaide – Australia
JIANG Zefei Beijing – China
MINAMI Hironobu Kobe – Japan
MOK Tony Hong-Kong – China
NAKAGAWA Kazuhiro Osaka – Japan
SAIJO Nagahiro Tokyo – Japan
SONG Erwei Guangzhou – China
THONGPRASERT Sumitra Chiang Mai – Thailand
XU Rui-Ha Guangzhou – China
AAPRO Matti S. Genolier – Switzerland
ADAM René Villejuif – France
AIMARD Lydie Marseille – France
ALTWEGG Thierry Dijon - France
ANDRE Fabrice Paris - France
AUCLERC Gérard Paris – France
AURENGO André Paris – France
AZIM Hamdy A. Mohandesien Giza – Egypt
BALDEYROU Pierre Paris – France
BANZET Pierre Paris – France
BASELGA José Barcelona - Spain
BASTIAN Gérard Paris - France
BENCHIMOL Daniel Nice - France
BLAY Jean-Yves Lyon – France
BOTTO Henry Suresnes – France
BOUDJEMA Karim Rennes – France
BRAMBILLA Elisabeth Grenoble – France
BRAMBILLA Christian Grenoble – France
BRASNU Daniel Paris – France
BRUHAT Maurice-Antoine Clermont-Ferrand – France
BUGAT Roland Toulouse – France BUYSE Marc Louvain la Neuve – Belgium
BUTHIAU Didier Paris – France
CADRANEL Jacques Paris – France
CALS Laurent Toulon – France
CALVO Fabien Paris – France
CARDE Patrice Villejuif – France
CASCINELLI Natale Milan – Italy
CHIRAS Jacques Paris – France
CONFORTI Rosa Paris – France
CONTE Pier-Franco Modena – Italy
CORTES Javier Barcelona – Spain
CORTES FUNES Hernan Madrid - Spain
COSSET Jean-Marc Paris – France
CROWN John Dublin – Ireland
CUNNINGHAM David London – UK
DALIVOUST Philippe Marseille – France
DANA Alain Paris – France
DAVYDOV Mikhail I. Moscow – Russia
DE GRAMONT Aimery Paris – France
DEAU Xavier Paris – France
DE BRAUD Filippo Milano - Italy
DELGADO Marian Paris – France
DEMIDOV Lev. V. Moscow – Russia
DEPLANQUE Gaël Paris – France
DIAZ-RUBIO Eduardo Madrid – Spain
DORVAL Thierry Paris – France
DOUILLARD Jean-Yves Nantes St Herblain – France
DROMAIN Clarisse Paris – France
DUCREUX Michel Villejuif – France
EGGERMONT Alexander Rotterdam - The Netherlands
ESCUDIER Bernard Villejuif – France
ETTORE Francette Nice – France
EXTRA Jean-Marc Marseille – France
FAIVRE Sandrine Villejuif – France
FITOUSSI Alfred Paris – France
FIZAZI Karim Villejuif – France
FOULT Jean-Marc Neuilly S/Seine – France
FUMOLEAU Pierre Dijon – France
GANDJBAKHCH Iradj Paris – France
GANEM Gérard Le Mans – France
GEORGOULIAS Vassilis Heraklion, Crete – Greece
GIANNI Luca Milano – Italy
GLIGOROV Joseph Paris – France
GUASTALLA Jean-Paul Lyon – France
HANNOUN Laurent Paris – France
HAROUSSEAU Jean-Luc Nantes - France
HARPER Peter London – UK
KHAYAT David Paris-France
KNOPF Alain Asnières – France
LACAU ST GUILY Jean Paris – France
LAUNOIS Bernard Paris – France
LE CESNE Axel Villejuif – France
LE CHEVALIER Thierry London - UK
LEJEUNE Ferdy Lausanne – Switzerland
LICHINITSER Michael Moscow – Russia
LINK Karl Heinrich Wiesbaden – Germany
LOUVET Christophe Paris – France
LUCIDARME Olivier Paris – France
LUDWIG Heinz Vienna – Austria
MAGNE Nicolas Paris – France
MARTIN Miguel Madrid – Spain
MARTIN Jean-Pierre Lyon – France
MARTY Michel Paris - France
MAZERON Jean-Jacques Paris – France
MILANO Gérard Nice – France
MORERE Jean-François Bobigny - France
MORNEX Françoise Lyon – France
MOUSSEAU Mireille Grenoble – France
MULARONI Elena Cailungo - San Marino
NAMER Moïse Nice – France
NIZRI Daniel Paris – France
PECORELLI Sergio Brescia – Italy
PENAULT-LLORCA F. Clermont-Ferrand – France
PICCART Martine Brussels – Belgium
PIVOT Xavier Besançon – France
RENODY Nicole Saint-Cloud – France
ROSELL Rafael Baladona – Spain
ROUËSSE Jacques Saint-Cloud – France
ROUGIER Philippe Paris – France
SALMON Rémy Paris – France
SCAGLIOTTI Georgio Turino – Italy
SCHMOLL Hans-Joachim Halle/Saale – Germany
SCHNEIDER Maurice Nice – France
SEITZ Jean-François Marseille – France
SMITH Ian Edward London – UK
SOBRERO Alberto Genoa – Italy
SORIA Jean-Charles Villejuif – France
SPANO Jean-Philippe Paris – France
SPIELMANN Marc Villejuif – France
STERNBERG Cora N. Roma – Italy
TABERNERO Josep Barcelona – Spain
TAILLADE Laurent Paris – France
THATCHER Nicholas Manchester – UK
TOURNIGAND Christophe Paris – France
TRILLET-LENOIR Véronique Lyon Pierre Bénite – France
TUBIANA Maurice Paris – France
UNTEREINER Michel Esch Alzette – Luxembourg
UZAN Serge Paris – France
VALLANCIEN Guy Paris – France
VAN CUTSEM Eric Leuven – Belgium
VAN LANSCHOT Jan Rotterdam – The Netherlands
VIGNOT Stéphane Paris – France
VUILLEMIN Eric Vannes – France
YCHOU Marc Montpellier - France
Founding PresidentPr Claude Jacquillat † Paris, France Honorary PresidentsPr Pierre Banzet Paris, FrancePr James Holland New York, USA
* Preliminary 3
21st International Scientific Committee*
Monday 1st February
Scientific Symposia are sessions during which some of the world best experts will, upon invitation, address different issues related to a specific topic. Each scientific symposium will end with a round table discussion and Q & A with the audience.
9:00-12:00
9:00-12:00 9:00-12:00
9:00-13:00
14:00-18:0014:00-18:00
12:30-13:30
12:30-13:30 12:30-13:30
13:00-14:00
14:00-17:00 14:00-17:00
Breast Cancer (1) Chaired by J. Cortes
SarcomaChaired by R. S. Benjamin
Head & Neck cancerChaired by TBC
Lung Cancer (1) Chaired by P. Harper
Lung Cancer (2) Chaired by G. Scagliotti
Breast Cancer (2) Chaired by G. N. Hortobagyi
Pharmaceutical Satellite Symposium
Pharmaceutical Satellite Symposium
Lunch
Lunch Symposium
Meet the Professors (MTP) Issues in New Drugs Development Chaired by M. Marty
Javier CORTES – Barcelona, SpainClifford HUDIS – New York, USASandra SWAIN – Washington, USA
Jean-Yves BLAY – Lyon, FranceAxel LE CESNE – Villejuif, FranceRobert S. BENJAMIN – Houston, USA
TBCTBCTBC
Gabriel N. HORTOBAGYI – Houston, USAMartine PICCART – Brussels, BelgiumNorman WOLMARK – Pittsburg, USAEdith PEREZ – Jacksonville, USA
Room 1
Room 3
9:00-12:00
14:00-17:00
12:30-13:30
Educational Lectures (EL)
Educational Lectures (EL)
Lunch Symposium
Room 59:00-12:00
14:00-17:00
12:30-13:30 Meet the Professors (MTP)
Educational Lectures (EL)
Pharmaceutical Satellite Symposium
Room 6
Room 4
Peter HARPER – London, UKMark G. KRIS – New York, USATony MOK – Hong Kong, ChinaNagahiro SAIJO – Tokyo, Japan
Georgio SCAGLIOTTI – Turino, ItalyFrances SHEPHERD – Toronto, CanadaRafael ROSELL – Baladona, Italy Thierry LE CHEVALIER – London, UK
Michel MARTY – Paris, FranceJean-Pierre BIZZARI – New York, USAMarc BUYSE – Louvain la Neuve, Belgium
Room 2
Scientific Symposium on Preliminary Program
54
Scientific Symposium on Preliminary Program
Tuesday 2nd February
9:00-13:00
9:00-12:00
9:00-13:00
14:00-17:0014:00-18:00
13:00-14:00
12:30-13:30
13:00-14:00
14:00-17:00
Gastrointestinal Tumors (1)Chaired by D. G. Haller
New Developments in Targeted Therapies Chaired by W.K. Hong
Breast Cancer (3) Chaired by J. Crown
Renal Cancer Chaired by J-P. Spano
Gastrointestinal Tumors (2) Chaired by L. Saltz
Lunch
Pharmaceutical Satellite Symposium
Lunch Symposium
Melanoma Chaired by A. Eggermont
Daniel G. HALLER – Philadelphia, USA
Eric VAN CUTSEM – Leuven, Belgium
Norman WOLMARK – Pittsburg, USA
Aimery DE GRAMONT – Paris, France
Waun Ki HONG – Houston, USA
Jean-Charles SORIA – Villejuif, France
TBC
Alexander EGGERMONT – Rotterdam, The Netherlands
Natale CASCINELLI – Milano, Italy
Ferdy LEJEUNE – Lausanne, Switzerland
John CROWN – Dublin, Ireland
Ian E. SMITH – London, UK
Pier-Franco CONTE – Modena, Italy
Pierre FUMOLEAU – Dijon, France
Jean-Philippe SPANO – Paris, France
Cora N. STERNBERG – Roma, Italy
Bernard ESCUDIER – Villejuif, France
Leonard SALTZ – New York, USA
Hans-Joachim SCHMOLL – Halle/Saale, Germany
Alberto SOBRERO – Genoa, Italy
Jean-Yves DOUILLARD – Nantes, France
Room 1
9:00-12:00
14:00-17:00
12:30-13:30
Educational Lectures (EL)
Educational Lectures (EL)Lunch
Room 6
12:30-13:30 Pharmaceutical Satellite Symposium
9:00-12:00
14:00-17:00
Educational Lectures (EL)
Educational Lectures (EL)
Room 5
Room 39:00-12:00
12:30-13:30
14:00-17:00
Meet the Professors (MTP)Lunch SymposiumMeet the Professors (MTP)
Room 4
Room 2
Wednesday 3rd February
15:30-17:30
9:00-12:00
Presidential sessionChaired by G.N. Hortobagyi & D. Khayat Program to be determined
Prostate CancerChaired by C.N. Sternberg
Cora N. STERNBERG – Roma, Italy
Matti S. AAPRO – Genolier, Switzerland Karim FIZAZI – Villejuif, France
11:15-12:45 Colorectal CancerChaired by A. Habr-Gama & E. Rullier
B. Heald – Basingstoke, UKW. Hohenberger – Erlangen, GermanyS.H. Kim – Seoul, South KoreaY. Panis – Clichy, France
14:15-15:45 Thoracic Surgical OncologyChaired by I. Gandjbakhch
V. Westeel – Besançon, FranceL. Samson – Montreal, Canada V. Ninane – Brussels, BelgiumP. Van Schil – Antwerpen, BelgiumC. Deschamps – Rochester, USA
Scientific Symposium on Preliminary Program
Educational Lectures (EL)*
Offer interdisciplinary or multidisciplinary explorations of focused areas of clinical oncology. They are designed for an audience of about 30 to 150 attendees. They allow the participants to interact with the leading oncology expert giving this lecture.
* Preliminary8
Javier Cortes Barcelona – Spain
Chemotherapy options in patients with anthracyclines and taxanes-pre-treated metastatic breast cancer
Clifford Hudis New York - USA
What is new in HER2 positive breast cancer?
Sandra Swain Whashington - USA
Adjuvant Therapy of Breast Cancer : Update 2010
Martine PiccartBrussels - Belgium
Breast Cancer Adjuvant Treatment Tailoring in 2010
Pier-Franco Conté Modena – Itlay
Achievements an Unmet needs in the management of epithelial ovarian cancer
Mark G. KrisNew York - USA
Preventing Nausea and vomiting caused by Anticancer Therapies
Tony MokHong Kong - China
Is maintenance Therapy a standard management of advanced NSCLC?
Nagahiro SaijoTokyo - Japan
Standardization of individualized therapy
Georgio ScagliottiTurino – Italy
Chemotherapy in early stage Non-Small Cell Lung Cancer
Rafael RosellBaladona - Spain
➢Pronostic Factors in Early NSCLC
Alexander Eggermont Rotterdam –The Netherlands
Sentinel node staging, Clinical true and false positivity, when is acompletion lymph node dissectionindicated?
Natale Cascinelli Milano - Italy
Cutaneous Melanoma
James O. ArmitageOmaha - USA
Peripheral TC Lymphoma
Daniel G. HallerPhiladelphia - USA
➢Adjuvant therapy of Colon Cancer
Kiyohiko Hatake Tokyo - Japan
CTC: surrogate marker for chemotherapy in colorectal cancer
Leonard SaltzNew York - USA
➢Adjuvant therapy of colon cancer
Alberto SobreroGenoa - Italy
Incremental advance or seismic shift: A proposal for a two level drugapproval system
FDG-PET in Early Clinical Trials of Molecular Target Drugs
Josep TaberneroBarcelona – Spain
Biomarkers in Phase II studies
Eric Van CutsemLeuven - Belgium
Biologicals in colorectal cancer
Sumitra Thongprasert Chiang Mai - Thailand
Management of advanced non-small cell lung cancer. How to selectappropriate treatment?
Margaret A. TemperoSan Francisco - USA
Strategies for Adjuvant Therapy of Pancreatic Cancer
Edith PerezJacksonville - USA
Translation research in BreastCancer
Matti S. AaproGenolier - Switzerland
Supporting the bone and the bone marrow
Hans-Joachim SchmollHalle/Saale - Germany
New Standards in AdvancedColorectal Cancer
Filippo De BraudMilano - Italy
Medical treatment of neuroendo-crine Tumors
Yasuhiro FujiwaraTokyo - Japan
Japenese (in comparison with EU&USA) pharmaceutical affair’s standard for new drug application or regulatory issues regarding onco-logy clinical research
Glyn JamiesonAdelaide - Australia
Problems in the staging of oesophageal cancer and their effect on reported outcomes of treatment
Educational Lectures - Meet the Professors
Meet the Professors (MTP)*
9
Javier Cortes Barcelona – Spain
Bevacizumab-based therapy inpa-tients with metastatic breast cancer: which dose and which partner?
Clifford HudisNew York - USA
Early Stage Breast Cancer
Pier-Franco ContéModena – Itlay
Advanced breast cancer: therapeutic options according to molecular subtypes and prior adjuvant treatments.
Eric Van CutsemLeuven - Belgium
The treatment of advanced gastric cancer
Sumitra Thongprasert Chiang Mai - Thailand
➢Biliary tract cancer
Margaret A. TemperoSan Francisco - USA
Pancreatic Cancer: Management of Advanced Disease
James O. Armitage Omaha - USA
Case Studies in Lymphoma
Hironobu MinamiKobe - Japan
Pharmacodynamics of Anti-Cancer Agents
Cora N. SternbergRoma - Italy
Prostate Cancer: Systemic Chemo-therapy and New ExperimentalApproaches
Alberto SobreroGenoa - Italy
Therapeutic advance decision ma-king in advanced colorectalcancer
Eduardo CazapBuenos Aires - Argentina
Clinical Cancer Research: Promoting International Research; Pharma Sponsored and Public Funded Trials
Rafael RosellBaladona – Spain
Reduction of Cancer Networks to Abstract Models for Identification of Therapy-Predictive Markers
Edith PerezJacksonville - USA
Trials that have significantly influen-ced standards of practice
Mark G. KrisNew York - USA
How do we speed up the develop-ment of new anticancer therapies?
Nagahiro SaijoTokyo - Japan
Pharmacogenomics of Lung Cancer
Meet the Professor Lectures are designed to enhance attendees’ learning experience: one recognized expert interprets, reviews and expands on one selected topic. They are designed for a small audience, not more than 50 persons. They are formatted to allow ample interaction between the speaker and the attendees.
Georgio ScagliottiTurino – Italy
➢Small Cell Lung Cancer
Alexander Eggermont Rotterdam –The Netherlands
Strategies to achieve limb salvage in locally advanced Soft Tissue Sarcoma
Daniel G. HallerPhiladelphia - USA
Writing a manuscript for an oncology journal
Matti S. AaproGenolier - Switzerland
Progress in Geriatric Oncology
Kiyohiko Hatake Tokyo - Japan
Treatment for rituximab-resistantB-cell lymphoma
Yasuhiro FujiwaraTokyo - Japan
Neoadjuvant chemotherapy translationa research of HER-2 positive breast cancer
Hamdy A. AzimMohandesien Giza - Egypt
HER-2/neu positive breast cancer
Glyn JamiesonAdelaide - Australia
The evidence base for radicallymphadenectomy in oesophagealcancer
Abstracts Accommodation
10
Submission Guidelines- Abstracts have to be submitted electronically and in English- Abstracts received after the deadline (November 13th, 2009) will not be considered- Supply as much information as possible: the precise subject of study, methods used where appropriate, summary of results obtained, conclusion- As it is assumed that original work will be presented, no bibliographic references are necessary- Selected abstracts will be published in the abstract book exactly as you submitted it. Therefore, proofreading is essential, no modification will be possible after submission.- Your abstract should not contain accents or any other invalid character, which would not be part of the English alphabet.- Your abstract’s text should not exceed 3,000 characters (excluding spaces)- The main author (presenter) confirms that all authors are aware of and agree to the content of the abstract and support of the data presented. By submitting his abstract, the author allows the 21th ICACT to publish and distribute or sell his abstract as part of the Abstract Book, which may be distributed on paper or CD Rom.- All selected abstracts will be published in the abstract book. Papers accepted for poster presentation will be displayed during poster sessions.- Acceptance or rejection of the paper by the Scientific Committee will be notified by email to the main author (presenter) by December 11th, 2009- Only persons whose registration is complete will be able to present their abstracts- Posters will be awarded or encouraged: a special jury will select the three best posters and their authors will receive the SOMPS Poster Award and a cheque of 500E each.
Special prices have been negotiated to offer you the best value for the period Both hotels are 4**** and offer the best situation :
HOTEL CONCORDE LAFAYETTE 3, place du Général Koenig - 75017 Paris, France T +33 (0) 1 40 68 50 68 - F +33 (0) 1 40 68 50 43 Web site : www.concorde-hotels.com
HOTEL LE MERIDIEN ETOILE 81, bd Gouvion Saint-Cyr, - 75017 Paris, france T +33 (0) 1 40 68 34 34 - F +33 (0) 1 40 68 31 31 Web site : www.lemeridien.com/etoile
Booking only by Email : infos@ im-events.com or fax + 331 47 43 22 26 or post mailPlease fill the Registration Form
PAYMENT AND AGREEMENT Deadline Registration for hotel room : December 30th 2009 Full payment upon registration
Cancellation Policy per room per night : • From October 30th to November 30th, 2009 : 50% cancellation fees • From December 1st to December 30th, 2009 : 75% cancellation fees • From December 31st, 2009 : rooms cancelled are non refundable • Name changes are authorized till January 15th, 2010. (Any change or cancellation must be validated by mail or fax)
Price per room, per night, Buffet breakfast & VAT included CLASSIC room per night for 1 or 2 persons : 185 ECLUB room per night for 1 or 2 persons : 285 E ➢
Price per room, per night, Buffet breakfast & VAT included CLASSIC room per night for 1 or 2 persons : 199 EDELUXE room per night for 1 or 2 persons : 229 E ➢
Registration (Allows to access all satellite meetings of ICACT)
REGISTRATION FEES (in Euros) Regular Registration Student*
From June. 15th 09 to Nov. 15th, 2009 380 170
From Nov. 16th 09 to Jan. 15th, 2010 500 225
From Jan. 16th, 2010 and on site 550 275
*Provided signed Certificate from the school is attached to the registration form
Way of RegistrationOnline Registration: secure online registration and payment by credit card via the website www.icact.comRegistration will be validated only with payment by credit card (Visa, Mastercard). Registration Form sent by Fax or Mail: you can download the registration form on the website and send it duly completed to the Organisation Commtte. Registration will be validated only with payment attached or credit card information completed.Cancellation PolicyBefore November 2nd, 2009 : 50% cancellation feesFrom November 3rd, 2009 : no refund
The airlines of SKYTEAM, Official Alliance Network for 21st ICACT 2010, offer attractive airfares for participants.SKYTEAM comprises 10 leading international airlines serving 728 cities in 149 countries with over 15 000 flights daily.
SkyTeam Global Meetings Agreement - This Agreement is entered into by and among member airlines of the SkyTeam Alliance and EQUATOUR
EQU
ATO
UR
- Lic
.075
9700
95 -
RC P
aris
B 34
3903
639
GLOBAL MEETINGS PROGRAMME - TICKETS PURCHASINGThe Discount Agreement will be for travel between January 27th through February 11th, 2010.
Through this site you can also access the schedules of all SkyTeam partners to plan your flights on the airline of your choice.As an added benefit you can earn miles every time you travel on a member airline.
To benefit from these special offers, link up with http://globalmeetings.skyteam.com and quote the Identifier Code 0804STickets purchased on the following Carriers are eligible for the SkyTeam Global Meetings programme: Aeroflot, Aeromexico, Alitalia,Continental Airlines, Korean Air, China Southern Airlines, Delta Airlines, Northwest Airlines, Air Europa, Copa Airlines, and Kenya Airways,Air France KLM -Tickets purchased online at www.airfranceklm-globalmeetings.comCSA Czech Airlines -Tickets purchased online at www.czechairlines.com